Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 13;67(11):1760-1767.
doi: 10.1093/cid/ciy356.

Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya

Affiliations

Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya

Aubree Gordon et al. Clin Infect Dis. .

Abstract

Background: Chikungunya, an arboviral disease, caused massive epidemics in Central and South America in 2014-2016. In a prospective pediatric cohort study, we examined the introduction of chikungunya in a naive population and investigated transmission and clinical characteristics.

Methods: Children presenting to the study health center with a chikungunya-like illness or undifferentiated fever were tested for chikungunya virus (CHIKV) infection by reverse transcriptase-polymerase chain reaction (RT-PCR) and serological assays. Inapparent CHIKV infections in the intervening year were determined by seroconversion in healthy blood samples collected annually.

Results: A total of 4353 children participated in the cohort study from March 2014 to February 2016 during the 2 epidemic waves of chikungunya. A total of 539 cases of chikungunya were documented, for an incidence rate of 80.2 cases per 1000 person-years (95% confidence interval [CI]: 73.7, 87.2); and a total of 893 CHIKV infections were documented, for an incidence rate of 137.1 infections per 1000 person-years (95% CI: 128.4, 146.4). The seroprevalence of anti-CHIKV antibodies increased linearly with age, with seroprevalence of >45% in 14-year-old children at the end of Epidemic 2. Symptom presentation varied between the epidemics, with Epidemic 2 exhibiting both a higher symptomatic-to-inapparent ratio (1:1.20 in Epidemic 1 vs. 1:0.65 in Epidemic 2) and more severe clinical presentation among cases. The mean reproduction number was also greater in Epidemic 2 than in Epidemic 1.

Conclusions: The intensity of transmission and severity of clinical presentation varied between the 2 epidemics, with higher transmission intensity associated with greater disease severity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Incidence of chikungunya cases in the cohort by study year and month, March 2014–February 2016.
Figure 2.
Figure 2.
Age effect on case incidence, infection incidence, and the number of symptomatic cases per infection.
Figure 3.
Figure 3.
Seroprevalence of anti-chikungunya virus antibodies by age in the cohort in 2016.

Comment in

References

    1. Pan American Health Organization. Geographic spread of chikungunya in the Americas, December 2013-December 2017, 2018. Available at: http://ais.paho.org/phip/viz/ed_chikungunya_amro.asp. Accessed 4 December 2018.
    1. Rosario en Multinoticias (9 de Julio de 2014). El 19 digital, 2014. Accessed 7 September 2014 https://www.el19digital.com/articulos/ver/titulo:20342-rosario-en-multin....
    1. Renault P, Balleydier E, D’Ortenzio E, Bâville M, Filleul L. Epidemiology of chikungunya infection on Reunion Island, Mayotte, and neighboring countries. Med Mal Infect 2012; 42:93–101. - PubMed
    1. Sergon K, Njuguna C, Kalani R, et al. Seroprevalence of chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg 2008; 78:333–7. - PubMed
    1. Sergon K, Yahaya AA, Brown J, et al. Seroprevalence of chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg 2007; 76:1189–93. - PubMed

Publication types

Substances